Over 1350 Total Lots Up For Auction at Two Locations - NJ Cleansweep 03/27, FL 03/31

Aidoc announces collaboration with AWS to advance clinical AI foundation models, transforming healthcare at scale

Press releases may be edited for formatting or style | January 21, 2025 Business Affairs

Integrating Aidoc's enterprise platform, aiOS™ with AWS, enhances its capabilities and allows seamless deployment across hospitals globally. This reduces IT complexity, allowing care teams to focus on patients instead of technology, and lowers the barrier for AI developers to create and scale solutions..

"Aidoc is on a mission to harness next-generation healthcare AI to drive better, more affordable care," said Tom Valent, chief business officer, Aidoc. "Our clinical-grade CARE™ Foundation Model and aiOS™ platform united with the scalability of AWS allow us to add more clinical AI vendors who want to leverage the technology to help bring more clinical AI into health systems with ease."

Over the next year, Aidoc will expand CARE™'s capabilities with new clinical AI upgrades working with AWS, aiming for FDA clearance on additional applications that address complex conditions. These advancements will be piloted in real-world settings with Aidoc's existing network of healthcare partners, ensuring they deliver measurable improvements in diagnostic speed, accuracy and patient care outcomes.


About Aidoc
Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Built on Aidoc's proprietary aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in over 1,200 medical centers worldwide, Aidoc leads the clinical AI industry with 17 FDA clearances, empowering physicians to make more informed decisions with real-time data. Visit Aidoc.com to see how we are connecting all points of care with always on AI.

Back to HCB News

You Must Be Logged In To Post A Comment